Literature DB >> 23295808

Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?

Harry Quon, Arlene A Forastiere.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23295808     DOI： 10.1200/JCO.2012.46.7746

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  21 in total

1.  Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Dominic H Moon; Felix Y Feng; Douglas B Chepeha; Avraham Eisbruch; Matthew H Stenmark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

2.  Do patients with head and neck human papillomavirus-related carcinoma need a different treatment approach?

Authors:  Jon Cacicedo Fernandez de Bobadilla; Pedro Bilbao
Journal:  Int J Clin Oncol       Date:  2013-08-06       Impact factor: 3.402

3.  Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Authors:  Frank Ziemann; Andrea Arenz; Stefanie Preising; Claus Wittekindt; Jens P Klussmann; Rita Engenhart-Cabillic; Andrea Wittig
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Jonathan B McHugh; Ka Kit Wong; Heather M Walline; Serena A Byrd; Christine M Komarck; Mohannad Ibrahim; Matthew H Stenmark; Mark E Prince; Carol R Bradford; Gregory T Wolf; Scott McLean; Francis P Worden; Douglas B Chepeha; Thomas Carey; Avraham Eisbruch
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

5.  Moving forward in HIV-associated cancer.

Authors:  Satish Gopal; Chad J Achenbach; Elizabeth L Yanik; Dirk P Dittmer; Joseph J Eron; Eric A Engels
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

Review 6.  Review: Head and neck squamous cell carcinoma in sub-Saharan Africa.

Authors:  C E Faggons; C Mabedi; C G Shores; S Gopal
Journal:  Malawi Med J       Date:  2015-09       Impact factor: 0.875

7.  Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Matthew H Stenmark; Carol R Bradford; Gregory T Wolf; Francis P Worden; Douglas B Chepeha; Jonathan B McHugh; Thomas Carey; Ka Kit Wong; Avraham Eisbruch
Journal:  Oral Oncol       Date:  2013-12-31       Impact factor: 5.337

8.  Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.

Authors:  Hong Li; Sina J Torabi; Wendell G Yarbrough; Saral Mehra; Heather A Osborn; Benjamin Judson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-06-01       Impact factor: 6.223

9.  Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.

Authors:  John D Cramer; Robert L Ferris; Seungwon Kim; Umamaheswar Duvvuri
Journal:  Oral Oncol       Date:  2018-11-13       Impact factor: 5.337

10.  Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Mohannad Ibrahim; Carol R Bradford; Gregory T Wolf; Matthew H Stenmark; Francis P Worden; Jonathan B McHugh; Mark E Prince; Thomas Carey; Douglas B Chepeha; Avraham Eisbruch
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.